Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25535-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- DLL3 antibody
- Antibody type
- Polyclonal
- Description
- DLL3 antibody (Cat. #25535-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients.
Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis.
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth.
Yuan C, Chang K, Xu C, Li Q, Du Z
Translational oncology 2021 Jul;14(7):101080
Translational oncology 2021 Jul;14(7):101080
Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis.
Liu Q, Song X, Liu Z, Yu Z
Technology in cancer research & treatment 2021 Jan-Dec;20:15330338211019506
Technology in cancer research & treatment 2021 Jan-Dec;20:15330338211019506
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth.
Chen X, Amar N, Zhu Y, Wang C, Xia C, Yang X, Wu D, Feng M
Journal for immunotherapy of cancer 2020 Jun;8(1)
Journal for immunotherapy of cancer 2020 Jun;8(1)
No comments: Submit comment
No validations: Submit validation data